MENU

ACRV Acrivon Therapeutics Forecast, Technical & Fundamental Analysis

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform... Show more

ACRV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
ACRV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ACRV is expected to report earnings to rise 42.86% to -69 cents per share on November 12

Acrivon Therapeutics ACRV Stock Earnings Reports
Q3'26
Est.
$-0.70
Q1'26
Beat
by $0.13
Q4'25
Beat
by $0.72
Q3'25
Beat
by $0.69
Q2'25
Beat
by $0.54
The last earnings report on May 13 showed earnings per share of -49 cents, beating the estimate of -62 cents. With 241.03K shares outstanding, the current market capitalization sits at 85.92M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 207-8979
Employees
76
Web
https://www.acrivon.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TWVLX9.430.06
+0.64%
American Century Value Inv
APAYX13.070.05
+0.38%
Integrity Dividend Summit A
JGRUX103.24N/A
N/A
JPMorgan US Value R4
TOLIX15.57N/A
N/A
DWS RREEF Global Infrastructure Inst
HFSFX18.87N/A
N/A
Hartford Schroders Intl Cntrrn Val F

ACRV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRV has been loosely correlated with ALLR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRV jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRV
1D Price
Change %
ACRV100%
-1.96%
ALLR - ACRV
48%
Loosely correlated
-2.40%
CRMD - ACRV
42%
Loosely correlated
-1.70%
IMRX - ACRV
41%
Loosely correlated
-6.56%
DNA - ACRV
39%
Loosely correlated
-0.44%
ABSI - ACRV
35%
Loosely correlated
-0.36%
More
Acrivon Therapeutics (ACRV) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com